Centrose
PrivateLast Round
Early Funding
Jan 24, 2014
Total Funding Raised
$1.28M
Company Overview
Centrose is a biotechnology company that develops Extracellular Drug Conjugates (EDCs) for targeted cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centrose Comparables
Compare Centrose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BlinkBio, Inc. | 79% | |
| Tagworks Pharmaceuticals | 77% | |
| Adcentrx Therapeutics | 76% | |
Centrose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 24, 2014 | ||||
| Grant | Jun 27, 2007 |
Centrose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors grew 749% MoM, from 141 to 1.2K.
- Jun 1, 2025
Monthly visitors increased 3793% MoM, from 14 to 545.
Centrose Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centrose's valuation, stock price, and market status.